Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1A-adrenoreceptor antagonist that relaxes smooth muscle in the prostate and bladder neck, improving urinary flow.
## Primary Indications
* Benign Prostatic Hyperplasia (BPH)
* Off-label: Medical Expulsive Therapy (MET) for distal ureteral stones
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* **Dose Titration:** If no response after 2–4 weeks, the dose may be increased to 0.8 mg daily.
* **Maximum Dose:** 0.8 mg daily.
## Pediatric Dosing
* **Safety/Efficacy:** Not established/FDA-approved for pediatric use. Dosage and safety in children are unknown; use is typically restricted to specialized urologic settings under strict protocols.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment necessary.
* **Hepatic Impairment:** Use caution in severe hepatic impairment (Child-Pugh Class C). Data on dosing in severe hepatic disease is limited; consult specialty guidelines.
## Contraindications
* Hypersensitivity to tamsulosin or any component of the formulation.
* Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin).
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde/reduced volume), asthenia, rhinitis.
* **Serious:** Orthostatic hypotension (rare, but increased risk with first dose), syncope, Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** May significantly increase tamsulosin serum concentrations.
* **Strong CYP2D6 Inhibitors:** (e.g., paroxetine, fluoxetine) May increase exposure; monitor for hypotension.
* **PDE-5 Inhibitors:** (e.g., sildenafil, tadalafil) May cause additive hypotensive effects; exercise caution.
## Monitoring
* **Baseline:** Blood pressure (especially if on concurrent antihypertensives).
* **Ongoing:** Monitor for symptomatic improvement (e.g., I-PSS score) and signs of orthostatic hypotension.
* **Surgical:** Inform ophthalmologist of current or prior use before scheduling cataract or glaucoma surgery.
## Clinical Pearls
* **Administration:** Must be taken 30 minutes after the same meal daily to ensure consistent pharmacokinetics. Do not crush or chew capsules.
* **Fall Risk:** Educate elderly patients on the risk of dizziness/syncope upon standing.
* **IFIS:** Tamsulosin can lead to IFIS during cataract surgery; it is generally recommended to withhold the drug prior to surgery, though the duration of benefit remains debated.
***
*Disclaimer: This information is for educational purposes and does not replace professional medical judgment. Dosing may vary based on local clinical protocols or specific patient conditions. Always verify current prescribing information through local pharmacy resources or updated clinical practice guidelines before administration.*
